Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
34,778
datasets available to search
ShareScore release 0.9.0
Dataset results
34,778 results for “diseases”
Study Exploring the Effect of Crizanlizumab on Kidney Function in Patients With Chronic Kidney Disease Caused by Sickle Cell Disease
ClinicalTrials.gov study NCT04053764. IPD Sharing: YES. Countries: 11. Publications: 2.
A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Have a History of Inadequate Response to or Intolerance to at Least One Disease Modifying Anti-Rheum
ClinicalTrials.gov study NCT03675308. IPD Sharing: YES. Countries: 39. Publications: 9.
Safety, Tolerability, PK and PD of Posiphen® in Subjects With Early Alzheimer's Disease
ClinicalTrials.gov study NCT02925650. IPD Sharing: YES. Countries: 1. Publications: 2.
Safety and Efficacy of LCI699 for the Treatment of Patients With Cushing's Disease
ClinicalTrials.gov study NCT02180217. IPD Sharing: YES. Countries: 19. Publications: 6.
Pharmacokinetics and Pharmacodynamics Study of SEG101 (Crizanlizumab) in Sickle Cell Disease (SCD) Patients With Vaso- Occlusive Crisis (VOC)
ClinicalTrials.gov study NCT03264989. IPD Sharing: YES. Countries: 1. Publications: 3.
An Open-label Study of Vedolizumab (MLN0002) in Participants With Ulcerative Colitis and Crohn's Disease
ClinicalTrials.gov study NCT00790933. IPD Sharing: YES. Countries: 10. Publications: 6.
Study Comparing Continuous Subcutaneous Infusion Of ABBV-951 With Oral Carbidopa/Levodopa Tablets For Treatment Of Motor Fluctuations In Adult Participants With Advanced Parkinson's Disease
ClinicalTrials.gov study NCT04380142. IPD Sharing: YES. Countries: 2. Publications: 3.
Study to Compare the Efficacy and Safety of Enzyme Replacement Therapies Avalglucosidase Alfa and Alglucosidase Alfa Administered Every Other Week in Patients With Late-onset Pompe Disease Who Have No
ClinicalTrials.gov study NCT02782741. IPD Sharing: YES. Countries: 25. Publications: 4.
Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)
ClinicalTrials.gov study NCT01410227. IPD Sharing: YES. Countries: 16. Publications: 1.
Vedolizumab in the Prophylaxis of Intestinal Acute Graft Versus Host Disease (aGVHD) in Participants Undergoing Allogeneic Hematopoietic Stem Cell (Allo-HSCT) Transplantation
ClinicalTrials.gov study NCT03657160. IPD Sharing: YES. Countries: 27. Publications: 1.
Daily Caloric Restriction and Intermittent Fasting in Overweight and Obese Adults With Autosomal Dominant Polycystic Kidney Disease
ClinicalTrials.gov study NCT03342742. IPD Sharing: YES. Countries: 1. Publications: 1.
Activity, Safety and Pharmacokinetics in Pediatric Subjects With Moderate and Severe Chronic Graft vs. Host Disease After Allogeneic Stem Cell Transplant
ClinicalTrials.gov study NCT03774082. IPD Sharing: YES. Countries: 14. Publications: 1.
Extended Access Program of Vedolizumab IV in Ulcerative Colitis and Crohn's Disease
ClinicalTrials.gov study NCT02743806. IPD Sharing: YES. Countries: 18. Publications: 1.
Study to Assess Efficacy and Safety of Cx601, Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Participants With Crohn's Disease (CD)
ClinicalTrials.gov study NCT03279081. IPD Sharing: YES. Countries: 15. Publications: 0.
PRV-015 in Gluten-free Diet Non-responsive Celiac Disease
ClinicalTrials.gov study NCT04424927. IPD Sharing: YES. Countries: 4. Publications: 0.
Triple Combination Therapy in High Risk Crohn's Disease (CD)
ClinicalTrials.gov study NCT02764762. IPD Sharing: YES. Countries: 2. Publications: 1.
A Study of PVP001, PVP002, and PVP003 in Healthy Adults and PVP001 and PVP002 in Adults With Celiac Disease
ClinicalTrials.gov study NCT03701555. IPD Sharing: YES. Countries: 1. Publications: 1.
Efficacy and Safety Evaluation of Osilodrostat in Cushing's Disease
ClinicalTrials.gov study NCT02697734. IPD Sharing: YES. Countries: 14. Publications: 3.
An Extension Trial of Inclisiran in Participants With Cardiovascular Disease and High Cholesterol
ClinicalTrials.gov study NCT03060577. IPD Sharing: YES. Countries: 5. Publications: 2.
Evaluation of Renvela in Patients With Chronic Kidney Disease Not On Dialysis And Hyperphosphatemia In China
ClinicalTrials.gov study NCT03001011. IPD Sharing: YES. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.